Health condition of climacteric women (non-diseased state)
Conditions
Interventions
Oral intake of placental extract-containing food (placental extract powder 300 mg/day for 12 weeks)
n=20
Oral intake of placebo (for 12 weeks)
n=20
Sponsors
Japan Society of Clinical Placenta Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (Subjects fulfilling all of the following criteria) 1) Climacteric women, who feels bad health, though are not in diseased state. 2) Agree to participate in the study and afford written informed consent.
Exclusion criteria
Exclusion criteria: (Subjects fulfilling at least one of the following criteria) 1) Pregnant or possibly pregnant. 2) Diagnosed as menopausal symptoms. 3) Using female hormone drugs. 4) Using drugs affecting female hormone state. 5) Using placental extract-containing drugs 6) SMI > 50 6) Lower serum E2 level (<=10 pg/mL) and higher serum FDH level (>=40 IU/mL). 7) Not agree to afford written informed consent. 8) Inappropriate as subjects by the decision of doctor in attendance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Simplified Menopausal Index (SMI) | — |
Secondary
| Measure | Time frame |
|---|---|
| serum estradiol (E2), serum follicle-stimulating hormone (FSH), safety | — |
Countries
Japan
Contacts
Public ContactMasami Ohishi
Snowden Co., Ltd. Academic Support Dept. Healthcare Marketing and Sales Div.
Outcome results
None listed